Abstract:Background The amplification of oncogenes initiated by high-risk human papillomavirus (HPV) infection is an early event in cervical carcinogenesis and can be used for cervical lesion diagnosis. We measured the genomic amplification rates and the patterns of human telomerase RNA gene (TERC) and C-MYC in the liquid-based cytological specimens to evaluate the diagnostic characteristics for the detection of high-grade cervical lesions. Methods Two hundred and forty-three residual cytological specimens were obtained from outpatients aged 25 to 64 years at Qilu Hospital, Shandong University. The specimens were evaluated by fluorescence in situ hybridization (FISH) using chromosome probes to TERC (3q26) and C-MYC (8q24). All of the patients underwent colposcopic examination and histological evaluation. A Chi-square test was used for categorical data analysis. Results In the normal, cervical intraepithelial neoplasia grade 1 (CIN1), grade 2 (CIN2), grade 3 (CIN3) and squamous cervical cancer (SCC) cases, the TERC positive rates were 9.2%, 17.2%, 76.2%, 100.0% and 100.0%, respectively; the C-MYC positive rates were 20.7%, 31.0%, 71.4%, 81.8% and 100.0%, respectively. The TERC and C-MYC positive rates were higher in the CIN2+ (CIN2, CIN3 and SCC) cases than in the normal and CIN1 cases ( p < 0.01). Compared with cytological analysis, the TERC test showed higher sensitivity (90.0% vs. 84.0%) and higher specificity (89.6% vs. 64.3%). The C-MYC test showed lower sensitivity (80.0% vs. 84.0%) and higher specificity (77.7% vs. 64.3%). Using a cut-off value of 5% or more aberrant cells, the TERC test showed the highest combination of sensitivity and specificity. The CIN2+ group showed more high-level TERC gene copy number (GCN) cells than did the normal/CIN1 group ( p < 0.05). For C-MYC, no significant difference between the two histological categories was detected ( p > 0.05). Conclusions The TERC test is highly sensitive and is therefore suitable for cervical cancer screening. The C-MYC test is not suitable for cancer screening because of its lower sensitivity. The amplification patterns of TERC become more diverse and complex as the severity of cervical diseases increases, whereas for C-MYC, the amplification patterns are similar between the normal/CIN1 and CIN2+ groups. Virtual slides The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1308004512669913 .

The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study

Detection Of Human Telomerase Rna Gene In Cervical Cancer And Precancerous Lesions Comparison With Cytological And Human Papillomavirus Dna Test Findings

Detection of TERC Amplification in Cervical Epithelial Cells for the Diagnosis of High-Grade Cervical Lesions and Invasive Cancer: A Multicenter Study in China

The Study of Genomic Amplification of the Human Telomerase Gene in Cytological Specimens by FISH for the Diagnosis of Cervical Dysplasia and Cervical Cacinoma

The significance of detection of genomic amplification of hTERC gene in cervical paraffin-embedded tissues in cervical cancer screening

Application of Hterc in Thinprep Samples with Mild Cytologic Abnormality and HR-HPV Positive

Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization.

Human Telomerase Rna Gene Amplification Detection Increases the Specificity of Cervical Intraepithelial Neoplasia Screening

Predictive Value of Detection of Hterc Gene Copy Number in Cervical Epithelial Cells by Means of Fluorescence in Situ Hybridization and Human Papilloma Virus Testing for Cervical Intraepitheliai Neoplasia

Clinical significance of fluorescence in situ hybridization detecting hTERC gene amplification in cervical epithelial cells in early diagnosis of uterine cervix cancer

The Application of Hterc Gene Amplification in Diagnosis and Treatment of Cervical Lesions

Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders.

Clinical Significance of Genotyping for Human Papillomavirus (HPV) 16 18/45 Combined with Cytology in Cervical Exfoliated Cells in HPV Oncogenic Mrna-Positive Women

Expression and clinical significance of telomerase gene and C-myc gene in cervical intraepithelial neoplasia

Genomic Amplification Patterns of Human Telomerase RNA Gene and C-MYC in Liquid-Based Cytological Specimens Used for the Detection of High-Grade Cervical Intraepithelial Neoplasia

[Evaluation of Genomic Amplification of the Human Telomerase RNA Component Gene in the Screening of Cervical Lesions].

Evaluation of human telomerase RNA gem amplification in the progression of uterine cervical dysplasia to invasive cancer by FISH detection

Different Amplification Patterns of the Human Telomerase RNA Gene in Invasive Cervical Carcinomas and Cervical Intraepithelial Neoplasia Grade III

Amplification of hTERC and c-MYC detected by FISH in screening of cervical cancer

[Clinical Application of Telomerase RNA Component Gene Amplification Assay in Cervical Lesions.].

Explore Genomic Relationship between HTERC Gene and the Corre-lation of High-Risk Human Papilloma Virus